[go: up one dir, main page]

DK1638971T3 - Fremstilling af substitueret Quinoxaliner fra dianilinen med 2,3-dihydroxy-1,4-dioxan - Google Patents

Fremstilling af substitueret Quinoxaliner fra dianilinen med 2,3-dihydroxy-1,4-dioxan

Info

Publication number
DK1638971T3
DK1638971T3 DK04734570T DK04734570T DK1638971T3 DK 1638971 T3 DK1638971 T3 DK 1638971T3 DK 04734570 T DK04734570 T DK 04734570T DK 04734570 T DK04734570 T DK 04734570T DK 1638971 T3 DK1638971 T3 DK 1638971T3
Authority
DK
Denmark
Prior art keywords
quinoxalins
dianiline
dihydroxy
dioxane
substituted
Prior art date
Application number
DK04734570T
Other languages
Danish (da)
English (en)
Inventor
Joseph Philip Rainville
Geraldine Patricia Taber
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=33511699&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1638971(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Application granted granted Critical
Publication of DK1638971T3 publication Critical patent/DK1638971T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08Bridged systems
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK04734570T 2003-06-04 2004-05-24 Fremstilling af substitueret Quinoxaliner fra dianilinen med 2,3-dihydroxy-1,4-dioxan DK1638971T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US47558903P 2003-06-04 2003-06-04
PCT/IB2004/001787 WO2004108725A1 (fr) 2003-06-04 2004-05-24 Preparation de quinoxalines substituees a partir de la dianiline avec du 2,3-dihydroxy-1,4-dioxane

Publications (1)

Publication Number Publication Date
DK1638971T3 true DK1638971T3 (da) 2008-10-27

Family

ID=33511699

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04734570T DK1638971T3 (da) 2003-06-04 2004-05-24 Fremstilling af substitueret Quinoxaliner fra dianilinen med 2,3-dihydroxy-1,4-dioxan

Country Status (17)

Country Link
US (1) US20070185327A1 (fr)
EP (1) EP1638971B1 (fr)
JP (1) JP2006526607A (fr)
AR (1) AR044472A1 (fr)
AT (1) ATE405566T1 (fr)
BR (1) BRPI0410613A (fr)
CA (1) CA2527337A1 (fr)
CL (1) CL2004001271A1 (fr)
DE (1) DE602004015986D1 (fr)
DK (1) DK1638971T3 (fr)
ES (1) ES2310730T3 (fr)
MX (1) MXPA05013084A (fr)
PL (2) PL1638971T3 (fr)
PT (1) PT1638971E (fr)
SI (1) SI1638971T1 (fr)
TW (1) TWI251594B (fr)
WO (1) WO2004108725A1 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0607838A2 (pt) * 2005-02-24 2009-06-13 Pfizer Prod Inc preparação de uma quinoxalina substituìda de pureza elevada
EP2268639A2 (fr) 2008-05-22 2011-01-05 Teva Pharmaceutical Industries Ltd. Tosylate de varénicline, un intermédiaire dans le procédé de préparation du l-tartrate de varénicline
US20090318695A1 (en) * 2008-06-19 2009-12-24 Vinod Kumar Kansal Processes for the preparation of varenicline and intermediates thereof
US8314235B2 (en) 2008-09-01 2012-11-20 Actavis Group Ptc Ehf Process for preparing varenicline, varenicline intermediates, pharmaceutically acceptable salts thereof
US8178537B2 (en) 2009-06-22 2012-05-15 Teva Pharmaceutical Industries Ltd. Solid state forms of varenicline salts and processes for preparation thereof
CA2791460A1 (fr) 2010-03-09 2011-09-15 Actavis Group Ptc Ehf Varenicline de haute purete ou son sel pharmaceutiquement acceptable sensiblement exempt d'impurete methylvarenicline
US20120004239A1 (en) 2010-06-11 2012-01-05 Medichem, S.A. Process for Preparing Quinoxaline Derivatives

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6605610B1 (en) * 1997-12-31 2003-08-12 Pfizer Inc Aryl fused azapolycyclic compounds
EA003190B1 (ru) * 1997-12-31 2003-02-27 Пфайзер Продактс Инк. Азаполициклические соединения, конденсированные с арилом
CA2443946A1 (fr) * 2001-04-20 2002-10-31 Pfizer Products Inc. Procede de preparation d'indenes 1,3-substitues et composes azapolycycliques d'aryle fondus

Also Published As

Publication number Publication date
EP1638971A1 (fr) 2006-03-29
SI1638971T1 (sl) 2008-12-31
TW200500365A (en) 2005-01-01
TWI251594B (en) 2006-03-21
CA2527337A1 (fr) 2004-12-16
WO2004108725A1 (fr) 2004-12-16
CL2004001271A1 (es) 2005-04-22
BRPI0410613A (pt) 2006-06-20
ES2310730T3 (es) 2009-01-16
PT1638971E (pt) 2008-10-23
ATE405566T1 (de) 2008-09-15
US20070185327A1 (en) 2007-08-09
MXPA05013084A (es) 2006-03-02
PL378491A1 (pl) 2006-05-02
PL1638971T3 (pl) 2009-01-30
EP1638971B1 (fr) 2008-08-20
JP2006526607A (ja) 2006-11-24
AR044472A1 (es) 2005-09-14
DE602004015986D1 (de) 2008-10-02

Similar Documents

Publication Publication Date Title
DK1620437T3 (da) 5,7-diaminopyrazolo-4,3-d-pyrimidiner, der er anvendelige til behandling af hypertension
FR2857406B1 (fr) Refroidissement des anneaux de turbine
DK1622880T3 (da) Substituerede dihydroquinazoliner med antivirale egenskaber
DK1778668T3 (da) Fremgangsmåde til fremstilling af dihydropteridion
DK1840125T3 (da) Mellemprodukter til fremstilling af dioxan-2-alkylcarbamater
DK1613694T3 (da) Polyalkenaminer med forbedrede anvendelsesegenskaber
DK1934327T3 (da) Mikroorganismer, der hæmmer dannelsen af armhulelugt
DK1597232T3 (da) Ny krystallinsk modifikation af anhydratet af boscalid
EP1608385A4 (fr) Compositions th rapeutiques
DK1667967T3 (da) Fremgangsmåde til fremstilling af 2-oxo-1-pyrrolidin-derivater
DK1682542T3 (da) Nyt krystallinsk anhydrat med anticholinerg effekt
DK1756049T3 (da) Fremgangsmåde til fremstilling af 1,4-diphenylazetidinon-derivater
DK1638971T3 (da) Fremstilling af substitueret Quinoxaliner fra dianilinen med 2,3-dihydroxy-1,4-dioxan
DK1678135T3 (da) Fremgangsm de til fremstilling af n-amino-substituerede hetorocykliske forbindelser
DK1838683T3 (da) Fremgangsmåde til fremstilling af [1,4,5]-oxadiazepinderivater
DK1846376T3 (da) Fremgangsmåde til fremstilling af 10,11-dihydro-10-hydroxy-5H-dibenz[b,f]azepin-5-carboxamid
DK1861389T3 (da) 7-(2-(4-(3-triflourmethylphenyl)-1,2,3,6-tetrahydro-pyrid-1-yl)ethyl)isoquinoleinbesylatsalt
DK1660485T3 (da) Forbedret fremgangsmåde til fremstilling af alpha-polymorfisk eletriptanhydrobromid
DK1831223T3 (da) Fremgangsmåde til fremstilling af L-biopterin
ITMI20032432A1 (it) Pentola
DK1511724T3 (da) Fremgangsmåde til fremstilling af thioalkylaminderivater
DK1692105T3 (da) Fremgangsmåde til fremstilling af (3-oxo-2,3-dihydro-1H-isoindol-1-yl)-acetylguanidin-derivater
DK1685104T3 (da) Fremgangsmåde til fremstilling af N-substituerede phthalomider
DK1786913T3 (da) Fremgangsmåde til fremstilling af diarylcycloalkylderivater
DK1833814T3 (da) Fremgangsmåde til fremstilling af substituerede 2-alkoxycarbonyl-3-aminothiophener